About this Course
UConn has developed web-based continuing pharmacy education activities to enhance the practice of pharmacists and assist pharmacists in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve. There are a total of 17.25 hours of CPE credit available. Successful completion of these 17.25 hours (13 activities) or equivalent training will prepare the pharmacist for the Anticoagulation Traineeship, which described below in the Additional Information Box.
The activities below are available separately for $17/hr or as a bundle price of $199 for all 13 activities (17.25 hours). These are the pre-requisites for the anticoagulation traineeship. Any pharmacist who wishes to increase their knowledge of anticoagulation may take any of the programs below.
When you are ready to submit quiz answers, go to the Blue "Take Test/Evaluation" Button.
Target Audience
Pharmacists who are interested in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve.
This activity is NOT accredited for technicians.
Pharmacist Learning Objectives
At the end of this application-based continuing education activity, the learner will be able to:
-Describe the physiology and pharmacology of vitamin K antagonists
-Identify key indications, contraindications, and adverse effects
-Explain the impact of genetics on warfarin dosing
-Examine anticoagulation needs in atrial fibrillation and valve disorders
-Outline INR goals, monitoring strategies, and patient counseling points
Release Date
Released: 07/15/2025
Expires: 07/15/2028
Course Fee
$17
ACPE UAN
ACPE #0009-0000-25-048-H01-P
Session Code
25AC48-WXT36
Accreditation Hours
1.0 hours of CE
Bundle Options
If desired, “bundle” pricing can be obtained by registering for the activities in groups. It consists of thirteen anticoagulation activities in our online selection.
You may register for individual topics at $17/CE Credit Hour, or for the Entire Anticoagulation Pre-requisite Series.
Pharmacist General Registration for 13 Anticoagulation Pre-requisite activities-(17.25 hours of CE) $199.00
In order to attend the 2-day Anticoagulation Traineeship, you must complete all of the Pre-requisite Series or the equivalent.
Additional Information
Anticoagulation Traineeship at the University of Connecticut Health Center, Farmington, CT
The University of Connecticut School of Pharmacy and The UConn Health Center Outpatient Anticoagulation Clinic have developed 2-day practice-based ACPE certificate continuing education activity for registered pharmacists and nurses who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy. This traineeship will provide you with both the clinical and administrative aspects of a pharmacist-managed outpatient anticoagulation clinic. The activity features ample time to individualize your learning experience. A “Certificate of Completion” will be awarded upon successful completion of the traineeship.
Accreditation Statement
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit for the online activity ACPE #0009-0000-25-048-H01-P will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.
Grant Funding
There is no grant funding for this activity.
Requirements for Successful Completion
To receive CE Credit go to Blue Button labeled "take Test/Evaluation" at the top of the page.
Type in your NABP ID, DOB and the session code for the activity. You were sent the session code in your confirmation email.
Faculty
Daniel Majerczyk Pharm.D., Ed.M., FCCP, BCPS, BC-ADM, CACP
Associate Professor of Clinical Sciences
Chair of Teaching and Academic Excellence
Roosevelt University
College of Science, Health and Pharmacy
Schaumburg, IL
Faculty Disclosure
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
Dr. Majerczyk has no relationships with an ineligible company and therefore has nothing to disclose.
Disclaimer
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
Program Content
Program Handouts
Post Test
View Questions for Vitamin K Antagonist Questions
1. What is the primary mechanism by which warfarin exerts its anticoagulant effect?
A. Inhibits thrombin directly
B. Inhibits vitamin K epoxide reductase (VKOR)
C. Inhibits platelet aggregation
2. Which clotting factor is most rapidly affected by warfarin therapy due to its short half-life?
A. Factor II (Prothrombin)
B. Factor X
C. Factor VII
3. A patient on warfarin starts amiodarone. What is the most appropriate clinical action?
A. Stop warfarin for 3 days
B. Increase warfarin dose
C. Monitor INR more frequently and adjust dose as needed
4. What is the INR goal range for a patient with a mechanical mitral valve?
A. 2.0–3.0
B. 2.5–3.5
C. 1.5–2.0
5. Which of the following best explains why warfarin requires an overlap with heparin during initiation?
A. Warfarin causes rapid bleeding initially
B. Protein C is depleted before procoagulant factors
C. Warfarin acts immediately on all clotting factors
6. A consistent intake of which nutrient is essential for patients taking warfarin?
A. Vitamin K
B. Vitamin B
C. Calcium
7. What is the most appropriate INR goal for a patient being treated for a DVT with warfarin?
A. 1.5–2.0
B. 2.0–3.0
C. 3.5–4.0
8. Which patient would most appropriately be started on a lower initial warfarin dose (≤5 mg)?
A. 25-year-old male with no comorbidities
B. 70-year-old female with heart failure and liver disease
C. 35-year-old woman with DVT and no medication interactions
9. What is the main reason INR needs to be monitored frequently during the first few weeks of warfarin therapy?
A. To detect liver toxicity
B. Because INR can fluctuate as factor levels change
C. To determine bone density
10. What is a major advantage of the On-X mechanical aortic valve compared to other mechanical valves?
A. It allows a lower INR goal
B. It requires no anticoagulation
C. It eliminates risk of thromboembolism
Additional Courses Available for Anticoagulation
Vitamin K Antagonist Pharmacology, Pharmacotherapy and Pharmacogenomics – 1 hour
Anticoagulation Management Pearls - 1 hour
Direct Oral Anticoagulants and Factor IIa and Xa Inhibitors – 1 hour
Laboratory Monitoring of Anticoagulation – 1 hour
Heparin/Low Molecular Weight Heparin and Fondaparinux Pharmacology and Pharmacotherapy – 0.5 hours
Developing an Anticoagulation Clinic – 1.0 hour
Pharmacist Reimbursement for Anticoagulation Services – 0.5 hour
Risk Management in Anticoagulation – 1 hour
Perioperative Management of Warfarin Interruption – 1 hour
Hypercoagulable States – 1 hour
Challenging Topics in Anticoagulation – 1 hour
Available Strategies to Reverse Anticoagulation Medications - 1 hour
Case Studies in Drug Interactions with Anticoagulation Therapy – 1 hour